Pharmerica (PMC) Reports In-Line Q2 EPS

August 9, 2016 8:07 AM EDT

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Pharmerica (NYSE: PMC) reported Q2 EPS of $0.47, in-line with the analyst estimate of $0.47. Revenue for the quarter came in at $519.6 million versus the consensus estimate of $508.31 million.Pharmerica reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment